Desipramine, commonly used as a noradrenergic neuroprotectant in 6-OHDA-lesions, leads to local functional changes in the urinary bladder and gastrointestinal tract in healthy rats

The 6-hydroxydopamine (6-OHDA) rat model is one of the most common animal models of Parkinson's disease. When experimentally inducing dopaminergic neurodegeneration in the nigrostriatal pathway using 6-OHDA, the noradrenergic reuptake inhibitor desipramine is often systemically injected in orde...

Descripción completa

Detalles Bibliográficos
Autores principales: Murillo, Maria del Pilar, Aronsson, Patrik, Winder, Michael, Carlsson, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679251/
https://www.ncbi.nlm.nih.gov/pubmed/33251357
http://dx.doi.org/10.1016/j.heliyon.2020.e05472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679251/
https://www.ncbi.nlm.nih.gov/pubmed/33251357
http://dx.doi.org/10.1016/j.heliyon.2020.e05472

Ejemplares similares